Patent US4603108A successfully refreshed from Google Patents.
US4603108A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for identification of bacterial species
Assignee: BTG International Ltd
•
Filing: 1982-11-08
•
Granted: 1986-07-29
•
Expires: 2002-11-08
Abstract
Abstract A method for identifying specific bacterial species in derived samples is based on 26 tests for the presence of constitutive enzymes, which, with the exception of two tests which require about two and a half hours, can be done relatively quickly, and without need for bacterial growth. By quantifying the amount of enzyme identified by the substrate test, a highly reliable identification of bacterial species present can be made. A kit, comprising substrates specific to the enzymes to be tested for, is provided for carrying out the test.
Inventors
- 👤 Shoshana Bascomb
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 02:23
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/34; C12Q1/02; C12Q1/04; Y; Y10; Y10S; Y10S435/00; Y10S435/81
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
209 words
In a procedure for use in the identification of bacteria, in which a bacterial sample to be identified is subjected to a combination of tests in which the sample is incubated with substrates for bacterial enzymes and the bacterial enzymes of the sample are determined by their interaction with the substrate to give rise to a detectable product, the improvement which comprises a quantitative determination of constitutive enzymes without depending on the growth of the bacteria, except in the case of tryptophanase and deoxyribonuclease, which require additional time, and comparing the results of the tests with a predetermined standard to identify bacterial species, using all of the following enzymes (a)-(z) in the test: (a) lipase (b) alpha-glucosidase (c) beta-glucosidase (d) beta-xylosidase (e) beta-glucuronidase (f) beta-galactosidase (g) whole cell acid phosphatase (h) acid phosphatase in the presence of agents which disrupt the bacterial cell permeability barrier (i) DL-alanyl-beta-naphthylamine specific peptidase (j) L-arginyl-beta-naphthylamine specific peptidase (k) N-gamma-L-glutamyl-beta-naphthylamine specific peptidase (l) glycyl-beta-naphthylamine specific peptidase (m) L-4-hydroxyprolyl-beta-naphthylamine specific peptidase (n) L-leucyl-beta-naphthylamine specific peptidase (o) L-leucyl-4-methoxy-beta-naphthylamine specific peptidase (p) L-lysyl-beta-naphthylamine specific peptidase (q) L-prolyl-beta-naphthylamine specific peptidase (r) L-pyrrolidonyl-beta-naphthylamine specific peptidase (s) alanyl-p-nitroaniline specific peptidase (t) glutamyl-p-nitroaniline specific peptidase (u) diacetyl/acetoin-producing enzymes (v) p-nitrophenylalanine ammonia-lyase (w) tryptophanase (x) deoxyribonuclease (y) glutamate decarboxylase (z) cytochrome oxidase.
Claim 2
Dependent Claim
209 words
In a procedure for use in the identification of bacteria, in which a bacterial sample to be identified is subjected to a combination of tests in which the sample is incubated with substrates for bacterial enzymes and the bacterial enzymes of the sample are determined by their interaction with the substrate to give rise to a detectable product, the improvement which comprises a quantitative determination of constitutive enzymes without depending on the growth of the bacteria, except in the case of tryptophanase and deoxyribonuclease, which require additional time, and comparing the results of the tests with a predetermined standard to identify bacterial species, using all of the following enzymes (a)-(z) in the test: (a) lipase (b) alpha-glucosidase (c) beta-glucosidase (d) beta-xylosidase (e) beta-glucuronidase (f) beta-galactosidase (g) whole cell acid phosphatase (h) acid phosphatase in the presence of agents which disrupt the bacterial cell permeability barrier (i) DL-alanyl-beta-naphthylamine specific peptidase (j) L-arginyl-beta-naphthylamine specific peptidase (k) N-gamma-L-glutamyl-beta-naphthylamine specific peptidase (l) glycyl-beta-naphthylamine specific peptidase (m) L-4-hydroxyprolyl-beta-naphthylamine specific peptidase (n) L-leucyl-beta-naphthylamine specific peptidase (o) L-leucyl-4-methoxy-beta-naphthylamine specific peptidase (p) L-lysyl-beta-naphthylamine specific peptidase (q) L-prolyl-beta-naphthylamine specific peptidase (r) L-pyrrolidonyl-beta-naphthylamine specific peptidase (s) alanyl-p-nitroaniline specific peptidase (t) glutamyl-p-nitroaniline specific peptidase (u) diacetyl/acetoin-producing enzymes (v) p-nitrophenylalanine ammonia-lyase (w) tryptophanase (x) deoxyribonuclease (y) glutamate decarboxylase (z) cytochrome oxidase.
Claim 3
Dependent Claim
33 words
The procedure according to claim 1, characterised in that the period of incubation is from about 10 minutes up to about 2 hours except for the tryptophanase and deoxyribonuclease tests (w) and (x).
Claim 4
Dependent Claim
30 words
The procedure according to claim 1, characterised in that the tryptophanase and deoxyribonuclease tests (w) and (x) are carried out with a period of incubation of 2 to 21/2 hours.
Claim 5
Dependent Claim
30 words
The procedure according to claim 2, characterised in that the tryptophanase and deoxyribonuclease tests (w) and (x) are carried out with a period of incubation of 2 to 21/2 hours.
Claim 6
Dependent Claim
31 words
The procedure according to claim 1, characterised in that the procedure is carried out on a sample derived from a single colony of bacteria produced by pre-culture of a clinical specimen.
Claim 7
Dependent Claim
31 words
The procedure according to claim 2, characterised in that the procedure is carried out on a sample derived from a single colony of bacteria produced by pre-culture of a clinical specimen.
Claim 8
Dependent Claim
27 words
The procedure according to claim 1, characterised in that a single procedure, using only the defined combination of tests, is used for identification of the bacterial sample.
Claim 9
Dependent Claim
27 words
The procedure according to claim 2, characterised in that a single procedure, using only the defined combination of tests, is used for identification of the bacterial sample.
Claim 10
Dependent Claim
28 words
A kit comprising reagents for use in a procedure according to claim 1, characterised by comprising separate specific substrates for each of the enzymes defined in claim 1.
Claim 11
Dependent Claim
24 words
The kit according to claim 9, characterised in that the enzyme substrates give rise to products which may be measured by fluorimetry or colorimetry.
Claim 12
Dependent Claim
16 words
The kit according to claim 10, characterised in that said kit includes colour-developing or fluorescence-developing reagent(s).
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-07-28 | 1990-01-27 | 1990-07-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-07-28 | 1994-01-27 | 1994-07-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-07-28 | 1998-01-27 | 1998-07-29 | $7700.00 | Window Closed / Lapsed |